Insiders · LIXT

LIXT insider transactions

Lixte Biotechnology Holdings Inc. (LIXT) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.

Recent Form 3, 4, and 5 filings for LIXT

• 23d
  Chief Financial Officer Stazzone Peter was granted 50,000 shares, increasing direct ownership by 100% to 100,000 units (SEC Form 4)

  4 - LIXTE BIOTECHNOLOGY HOLDINGS, INC. (0001335105) (Issuer)
• 23d
  Director Sawyer Jason David was granted 40,000 shares, increasing direct ownership by 160% to 65,000 units (SEC Form 4)

  4 - LIXTE BIOTECHNOLOGY HOLDINGS, INC. (0001335105) (Issuer)
• 23d
  CEO and Chairman of the Board Pursglove Geordan Garrett was granted 350,000 shares, increasing direct ownership by 100% to 700,000 units (SEC Form 4)

  4 - LIXTE BIOTECHNOLOGY HOLDINGS, INC. (0001335105) (Issuer)
• 23d
  Director Primus Guy Warren was granted 15,000 shares, increasing direct ownership by 60% to 40,000 units (SEC Form 4)

  4 - LIXTE BIOTECHNOLOGY HOLDINGS, INC. (0001335105) (Issuer)
• 23d
  Director Holloway Michael Andrew was granted 15,000 shares, increasing direct ownership by 60% to 40,000 units (SEC Form 4)

  4 - LIXTE BIOTECHNOLOGY HOLDINGS, INC. (0001335105) (Issuer)
• 23d
  Director Felix Lourdes was granted 30,000 shares, increasing direct ownership by 120% to 55,000 units (SEC Form 4)

  4 - LIXTE BIOTECHNOLOGY HOLDINGS, INC. (0001335105) (Issuer)
• 23d
  SEC Form 3 filed by new insider Travaglini John Francis

  3 - LIXTE BIOTECHNOLOGY HOLDINGS, INC. (0001335105) (Issuer)
• 54d
  Director Porter Stuart D was granted 25,000 shares (SEC Form 4)

  4 - LIXTE BIOTECHNOLOGY HOLDINGS, INC. (0001335105) (Issuer)
• 54d
  SEC Form 3 filed by new insider Porter Stuart D

  3 - LIXTE BIOTECHNOLOGY HOLDINGS, INC. (0001335105) (Issuer)
• 99d
  SEC Form 4 filed by Felix Lourdes

  4 - LIXTE BIOTECHNOLOGY HOLDINGS, INC. (0001335105) (Issuer)
• 99d
  SEC Form 4 filed by Pursglove Geordan Garrett

  4 - LIXTE BIOTECHNOLOGY HOLDINGS, INC. (0001335105) (Issuer)
• 99d
  SEC Form 4 filed by Stazzone Peter

  4 - LIXTE BIOTECHNOLOGY HOLDINGS, INC. (0001335105) (Issuer)
• 99d
  SEC Form 4 filed by Sawyer Jason David

  4 - LIXTE BIOTECHNOLOGY HOLDINGS, INC. (0001335105) (Issuer)
• 99d
  SEC Form 4 filed by Holloway Michael Andrew

  4 - LIXTE BIOTECHNOLOGY HOLDINGS, INC. (0001335105) (Issuer)
• 99d
  SEC Form 4 filed by Primus Guy Warren

  4 - LIXTE BIOTECHNOLOGY HOLDINGS, INC. (0001335105) (Issuer)
• 208d
  SEC Form 4 filed by Director Felix Lourdes

  4 - LIXTE BIOTECHNOLOGY HOLDINGS, INC. (0001335105) (Issuer)
• 208d
  SEC Form 4 filed by Director Primus Guy Warren

  4 - LIXTE BIOTECHNOLOGY HOLDINGS, INC. (0001335105) (Issuer)
• 318d
  SEC Form 3 filed by new insider Primus Guy Warren

  3 - LIXTE BIOTECHNOLOGY HOLDINGS, INC. (0001335105) (Issuer)
• 324d
  SEC Form 4 filed by Chief Financial Officer Stazzone Peter

  4 - LIXTE BIOTECHNOLOGY HOLDINGS, INC. (0001335105) (Issuer)
• 324d
  SEC Form 3 filed by new insider Stazzone Peter

  3 - LIXTE BIOTECHNOLOGY HOLDINGS, INC. (0001335105) (Issuer)
• 324d
  SEC Form 3 filed by new insider Felix Lourdes

  3 - LIXTE BIOTECHNOLOGY HOLDINGS, INC. (0001335105) (Issuer)
• 341d
  SEC Form 4 filed by Director Sawyer Jason David

  4 - LIXTE BIOTECHNOLOGY HOLDINGS, INC. (0001335105) (Issuer)
• 341d
  SEC Form 4 filed by Director Holloway Michael Andrew

  4 - LIXTE BIOTECHNOLOGY HOLDINGS, INC. (0001335105) (Issuer)
• 369d
  SEC Form 3 filed by new insider Holloway Michael Andrew

  3 - LIXTE BIOTECHNOLOGY HOLDINGS, INC. (0001335105) (Issuer)
• 369d
  SEC Form 3 filed by new insider Sawyer Jason David

  3 - LIXTE BIOTECHNOLOGY HOLDINGS, INC. (0001335105) (Issuer)
• 381d
  SEC Form 4 filed by CEO and Chairman of the Board Pursglove Geordan Garrett

  4 - LIXTE BIOTECHNOLOGY HOLDINGS, INC. (0001335105) (Issuer)
• 381d
  SEC Form 4 filed by Director Yen Yun

  4 - LIXTE BIOTECHNOLOGY HOLDINGS, INC. (0001335105) (Issuer)
• 382d
  SEC Form 4 filed by Director Brown Regina

  4 - LIXTE BIOTECHNOLOGY HOLDINGS, INC. (0001335105) (Issuer)
• 382d
  SEC Form 4 filed by Director Forman Stephen J.

  4 - LIXTE BIOTECHNOLOGY HOLDINGS, INC. (0001335105) (Issuer)
• 382d
  SEC Form 4 filed by Director Bernards Rene

  4 - LIXTE BIOTECHNOLOGY HOLDINGS, INC. (0001335105) (Issuer)
• 402d
  SEC Form 3 filed by new insider Pursglove Geordan Garrett

  3 - LIXTE BIOTECHNOLOGY HOLDINGS, INC. (0001335105) (Issuer)
• 479d
  SEC Form 4 filed by Director Brown Regina

  4 - LIXTE BIOTECHNOLOGY HOLDINGS, INC. (0001335105) (Issuer)
• 479d
  SEC Form 4 filed by Director Bernards Rene

  4 - LIXTE BIOTECHNOLOGY HOLDINGS, INC. (0001335105) (Issuer)
• 479d
  SEC Form 4 filed by Director Forman Stephen J.

  4 - LIXTE BIOTECHNOLOGY HOLDINGS, INC. (0001335105) (Issuer)
• 479d
  SEC Form 4 filed by Director Yen Yun

  4 - LIXTE BIOTECHNOLOGY HOLDINGS, INC. (0001335105) (Issuer)
• 549d
  SEC Form 4 filed by Director Forman Stephen J.

  4 - LIXTE BIOTECHNOLOGY HOLDINGS, INC. (0001335105) (Issuer)
• 549d
  SEC Form 4 filed by Director Yen Yun

  4 - LIXTE BIOTECHNOLOGY HOLDINGS, INC. (0001335105) (Issuer)
• 549d
  SEC Form 4 filed by Director Brown Regina

  4 - LIXTE BIOTECHNOLOGY HOLDINGS, INC. (0001335105) (Issuer)
• 549d
  SEC Form 4 filed by Director Bernards Rene

  4 - LIXTE BIOTECHNOLOGY HOLDINGS, INC. (0001335105) (Issuer)
• 634d
  SEC Form 4 filed by Director Forman Stephen J.

  4 - LIXTE BIOTECHNOLOGY HOLDINGS, INC. (0001335105) (Issuer)
• 634d
  SEC Form 4 filed by Director Bernards Rene

  4 - LIXTE BIOTECHNOLOGY HOLDINGS, INC. (0001335105) (Issuer)
• 634d
  SEC Form 4 filed by Director Brown Regina

  4 - LIXTE BIOTECHNOLOGY HOLDINGS, INC. (0001335105) (Issuer)
• 634d
  SEC Form 4 filed by Director Yen Yun

  4 - LIXTE BIOTECHNOLOGY HOLDINGS, INC. (0001335105) (Issuer)
• 723d
  SEC Form 3 filed by new insider Schellens Johannes Henricus Matthias

  3 - LIXTE BIOTECHNOLOGY HOLDINGS, INC. (0001335105) (Issuer)
• 750d
  SEC Form 4 filed by Director Bernards Rene

  4 - LIXTE BIOTECHNOLOGY HOLDINGS, INC. (0001335105) (Issuer)
• 753d
  SEC Form 4 filed by Director Yen Yun

  4 - LIXTE BIOTECHNOLOGY HOLDINGS, INC. (0001335105) (Issuer)
• 753d
  SEC Form 4 filed by Director Forman Stephen J.

  4 - LIXTE BIOTECHNOLOGY HOLDINGS, INC. (0001335105) (Issuer)
• 753d
  SEC Form 4 filed by Director Brown Regina

  4 - LIXTE BIOTECHNOLOGY HOLDINGS, INC. (0001335105) (Issuer)
• 1013d
  SEC Form 4 filed by Van Der Baan Bastiaan Jeroen

  4 - LIXTE BIOTECHNOLOGY HOLDINGS, INC. (0001335105) (Issuer)
• 1024d
  Bernards Rene bought $24,116 worth of shares (10,000 units at $2.41), increasing direct ownership by 67% to 25,000 units (SEC Form 4) (Amendment)

  4/A - LIXTE BIOTECHNOLOGY HOLDINGS, INC. (0001335105) (Issuer)
• 1024d
  Van Der Baan Bastiaan Jeroen bought $28,000 worth of shares (10,000 units at $2.80), increasing direct ownership by 1,000% to 11,000 units (SEC Form 4)

  4 - LIXTE BIOTECHNOLOGY HOLDINGS, INC. (0001335105) (Issuer)
• 1025d
  Bernards Rene bought $24,116 worth of shares (10,000 units at $2.41), increasing direct ownership by 33% to 20,000 units (SEC Form 4)

  4 - LIXTE BIOTECHNOLOGY HOLDINGS, INC. (0001335105) (Issuer)
• 1032d
  SEC Form 4 filed by Van Der Baan Bastiaan Jeroen

  4 - LIXTE BIOTECHNOLOGY HOLDINGS, INC. (0001335105) (Issuer)
• 1114d
  SEC Form 4 filed by Van Der Baan Bastiaan Jeroen

  4 - LIXTE BIOTECHNOLOGY HOLDINGS, INC. (0001335105) (Issuer)
• 1114d
  SEC Form 4 filed by Yen Yun

  4 - LIXTE BIOTECHNOLOGY HOLDINGS, INC. (0001335105) (Issuer)
• 1114d
  SEC Form 4 filed by Brown Regina

  4 - LIXTE BIOTECHNOLOGY HOLDINGS, INC. (0001335105) (Issuer)
• 1114d
  SEC Form 4 filed by Forman Stephen J.

  4 - LIXTE BIOTECHNOLOGY HOLDINGS, INC. (0001335105) (Issuer)
• 1297d
  SEC Form 4: Van Der Baan Bastiaan Jeroen bought $4,900 worth of shares (10,000 units at $0.49) (Amendment)

  4/A - LIXTE BIOTECHNOLOGY HOLDINGS, INC. (0001335105) (Issuer)
• 1298d
  SEC Form 4: Van Der Baan Bastiaan Jeroen bought $49,000 worth of shares (10,000 units at $4.90)

  4 - LIXTE BIOTECHNOLOGY HOLDINGS, INC. (0001335105) (Issuer)
• 1317d
  SEC Form 4: Bernards Rene bought $7,650 worth of shares (15,000 units at $0.51), increasing direct ownership by 11% to 150,000 units

  4 - LIXTE BIOTECHNOLOGY HOLDINGS, INC. (0001335105) (Issuer)